Pharmaceutical Management Agency (Pharmac)
Supply of iron (as ferric carboxymaltose) infusion
Supply of iron (as ferric carboxymaltose) infusion is a funding opportunity from Pharmaceutical Management Agency (Pharmac), closing December 16, 2026.
Overview
This is a competitive process for supply of iron (as ferric carboxymaltose) infusion for use in community and hospital settings. Iron infusion is indicated for the treatment of iron-deficiency anaemia. The proposed outcomes of this procurement are to make savings in the medicines budget, and to potentially widen or…